Risk for human African trypanosomiasis, Central Africa, 2000-2009.
about
Estimating and mapping the population at risk of sleeping sicknessAdvances and Limitations of Disease Biogeography Using Ecological Niche ModelingRecent developments in drug discovery for leishmaniasis and human African trypanosomiasisGlossina fuscipes populations provide insights for human African trypanosomiasis transmission in UgandaLarge-scale spatial population databases in infectious disease researchAssembling a geospatial database of tsetse-transmitted animal trypanosomosis for AfricaMonitoring the elimination of human African trypanosomiasis: Update to 2014In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sicknessGenetic dissection of drug resistance in trypanosomesIncorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in UgandaMonitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis.Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and riskPharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasisMapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis.Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination
P2860
Q21092278-9EFCB6FA-66C1-413C-B0EE-10D381A6D073Q26700075-E21FEADE-B4B2-4149-92B4-9BF94926CA09Q27011766-490EDF15-64C0-4251-8794-2D17FB71535FQ27012611-43823431-E7FD-4215-89E4-4C5CF9961A0DQ28730483-625FAC10-6049-45BA-8628-1D9484957502Q30577749-6A7C302C-4850-4B9D-8030-D002D623B979Q33758003-CE4B5FA6-D9CC-4FE3-93BF-1A58ADA79E47Q34058294-7A474136-3CAA-472D-9FE1-63DE4632F8A8Q34647009-BC117FC7-2328-4595-BEAE-C8826F67AC16Q35097828-10DDAFA3-29E1-41BA-B0A9-7D79A2B026FEQ35657780-63623F45-D57B-4ED8-B284-2196C8FAB702Q35848347-537D1112-E5CF-4E5A-803B-16EE9B16E647Q37263574-3CE0F618-0DE7-4DB9-9F42-9CBDA3F719C6Q37609404-FC855A6A-687F-4EE0-ABB9-94304066A326Q39254761-D011C373-B6E7-4B44-8BF0-FF9D0B1B64ACQ58843335-150AF85A-B7CC-49DA-B06D-504B6C56448C
P2860
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@ast
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@en
type
label
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@ast
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@en
prefLabel
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@ast
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@en
P2093
P2860
P356
P1476
Risk for human African trypanosomiasis, Central Africa, 2000-2009.
@en
P2093
Abdoulaye Diarra
Giuliano Cecchi
Jean G Jannin
José Antonio Ruiz Postigo
José R Franco
Massimo Paone
Pere P Simarro
Raffaele C Mattioli
P2860
P304
P356
10.3201/EID1712.110921
P50
P577
2011-12-01T00:00:00Z